Özdirik, B.; Maibier, M.; Scherf, M.; Nicklaus, J.M.; Frohme, J.; Puengel, T.; Meyer zum Büschenfelde, D.; Tacke, F.; Mueller, T.; Sigal, M.
Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis. J. Clin. Med. 2022, 11, 2479.
https://doi.org/10.3390/jcm11092479
AMA Style
Özdirik B, Maibier M, Scherf M, Nicklaus JM, Frohme J, Puengel T, Meyer zum Büschenfelde D, Tacke F, Mueller T, Sigal M.
Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis. Journal of Clinical Medicine. 2022; 11(9):2479.
https://doi.org/10.3390/jcm11092479
Chicago/Turabian Style
Özdirik, Burcin, Martin Maibier, Maria Scherf, Jule Marie Nicklaus, Josephine Frohme, Tobias Puengel, Dirk Meyer zum Büschenfelde, Frank Tacke, Tobias Mueller, and Michael Sigal.
2022. "Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis" Journal of Clinical Medicine 11, no. 9: 2479.
https://doi.org/10.3390/jcm11092479
APA Style
Özdirik, B., Maibier, M., Scherf, M., Nicklaus, J. M., Frohme, J., Puengel, T., Meyer zum Büschenfelde, D., Tacke, F., Mueller, T., & Sigal, M.
(2022). Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis. Journal of Clinical Medicine, 11(9), 2479.
https://doi.org/10.3390/jcm11092479